Alta Sciences

SEPTEMBER 27, 2024

This issue also covers classes of immunomodulators, including monoclonal antibodies, CAR-T cells, and vaccines; immunotherapy trials, focusing on complex study designs and diverse patient populations; and bioanalytical methods and assays, including pharmacokinetics and anti-drug antibodies (ADA).

Clinical Trials 52

Clinical Trials Trials Pharmacokinetics Small Molecule 52

PerkinElmer

JANUARY 7, 2020

Drug discovery is always evolving. From new processes to advanced technologies, excellence in drug discovery is the result of combining different approaches. Emerging and Resurrecting Technologies We’ve made huge strides in the drug discovery process, and it’s only getting better as we move forward.

Small Molecule 52

Small Molecule Cell Based Assays Drugs Drug Development 52

PerkinElmer

SEPTEMBER 8, 2019

Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe. Learn more about Cisbio here.

Cell Based Assays 52

Cell Based Assays Small Molecule Science Pharmaceuticals 52

Broad Institute

JUNE 30, 2023

The researchers also looked at the tool’s ability to detect changes in cellular phenotypes after exposure to drugs and small molecule compounds. Typically, studying drug therapies is an expensive and time-consuming undertaking.

Small Molecule 105

Small Molecule Cell Based Assays Disease Assay Development 105

Broad Institute

JUNE 21, 2023

The researchers also looked at the tool’s ability to detect changes in cell morphology after exposure to drugs and small molecule compounds. Typically, studying drug therapies is an expensive and time-consuming undertaking.

Small Molecule 52

Small Molecule Cell Based Assays Medical Schools Disease 52

Molecular Design

DECEMBER 31, 2023

BW2014 has been heavily cited in the drug discovery literature (it was cited as the first reference in the ACS assay interference editorial which I reviewed in K2017 ) despite providing nothing in the way of practical advice for dealing with nuisance behavior. Given that M2003 had been published over a decade previously.

Drugs 98

Drugs Packaging Cell Based Assays Small Molecule 98

Molecular Design

DECEMBER 19, 2023

Covalent bond formation between ligands and targets is a drug design tactic for exploiting molecular recognition elements in targets that are difficult to make beneficial contacts with. This Perspective is intended to jumpstart this important scientific discussion. Subscripting doesn't work well in blogger and so I'll use K.i

Small Molecule 66

Small Molecule Biochemical Assays Cell Based Assays Drugs 66